NatureCell Co Ltd
KOSDAQ:007390
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
NatureCell Co Ltd
Net Income (Common)
NatureCell Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NatureCell Co Ltd
KOSDAQ:007390
|
Net Income (Common)
-₩2.8B
|
CAGR 3-Years
25%
|
CAGR 5-Years
32%
|
CAGR 10-Years
-8%
|
|
|
Celltrion Inc
KRX:068270
|
Net Income (Common)
₩1T
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
22%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Net Income (Common)
-₩15.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Net Income (Common)
-₩32.6B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Net Income (Common)
₩141.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
61%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Net Income (Common)
-₩37.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
NatureCell Co Ltd
Glance View
NATURECELL Co., Ltd. engages in the research and development of stem cells. The company is headquartered in Seoul, Seoul and currently employs 126 full-time employees. The firm operates its business through three segments. The Stem Cell Business segment is engaged in the development of stem cell therapeutics, the manufacture of stem cell culture media, the development and sale of stem cell culture cosmetics, and the provision of blood cell storage services, among others. The Food Business segment is engaged in the manufacture and sale of fruit beverages including tomato juice, peach juice and others, canned beverages such as sikhye, fruit concentrates and others, as well as fermentation and health functional foods. The Hygiene Business segment is engaged in the manufacture and sale of health hygiene products such as masks, disinfectants, wipes, and others.
See Also
What is NatureCell Co Ltd's Net Income (Common)?
Net Income (Common)
-2.8B
KRW
Based on the financial report for Dec 31, 2025, NatureCell Co Ltd's Net Income (Common) amounts to -2.8B KRW.
What is NatureCell Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-8%
The average annual Net Income (Common) growth rates for NatureCell Co Ltd have been 25% over the past three years , 32% over the past five years , and -8% over the past ten years .
